Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 CAD | 0.00% | +10.00% | -21.43% |
05-15 | Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-01 | Resverlogix Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
11.1M | - | - | - | - | - | |
122B | ||||||
112B | ||||||
25.91B | - | |||||
19.33B | - | |||||
16.17B |
- Stock Market
- Equities
- RVX Stock
- Charts Resverlogix Corp.
- Sector Chart